With both scientific backing and cultural spotlight, its no surprise these medications are so popular right now." And where market trends go, so celebrity influencers tend to follow - hot on the heels of Ozempic's popularity has come a wave of so-called "natural" alternatives claiming to support weight loss by stimulating the production of an appetite-suppressing hormone known as GLP-1
Inconsistent levels lead to poor results and frustration
A total of 1,961 adult participants with a BMI of at least 30 or at least 27 with at least one weight-related comorbidity were randomized to receive either semaglutide (2.4 mg) or placebo, administered subcutaneously once weekly, along with lifestyle intervention

Hyperkalemia is a common electrolyte abnormality among patients with cardio-kidney-metabolic syndrome and has potentially life-threatening consequences.[1-3] Hyperkalemia is more commonly seen in patients with chronic kidney disease, heart failure, and diabetes, given the underlying pathophysiology and exposure to guideline-based medications such as renin-angiotensin-aldosterone system inhibitors (RAASis) and mineralocorticoid receptor antagonists (MRAs).[4,5] However, despite well-established recommendations for managing acute hyperkalemia in inpatient settings, guidelines for outpatient management remain limited.[6] Available data and recommendations are often extrapolated from the inpatient setting, where the severity of concomitant illnesses in hospitalized patients may lead to recommendations for outpatients to be referred to the emergency department for monitoring.[5] These broad-stroke recommendations create further stress and anxiety for the patient, physician, and health care system
